The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $0.34 in the prior trading day, Clearside Biomedical Inc (NASDAQ: CLSD) closed at $0.35, up 3.66%. In other words, the price has increased by $3.66 from its previous closing price. On the day, 1.72 million shares were traded. CLSD stock price reached its highest trading level at $0.3945 during the session, while it also had its lowest trading level at $0.33.
Ratios:
Our goal is to gain a better understanding of CLSD by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.19 and its Current Ratio is at 3.19.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 24 ’25 when Thorp Clay bought 15,000 shares for $0.92 per share. The transaction valued at 13,800 led to the insider holds 176,141 shares of the business.
Chong Ngai Hang Victor bought 36,500 shares of CLSD for $36,500 on Nov 01 ’24. The Chief Medical Officer now owns 100,000 shares after completing the transaction at $1.00 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLSD now has a Market Capitalization of 27306764 and an Enterprise Value of 66774192. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.26. Its current Enterprise Value per Revenue stands at 17.74 whereas that against EBITDA is -2.609.
Stock Price History:
The Beta on a monthly basis for CLSD is 2.10, which has changed by -0.6947826 over the last 52 weeks, in comparison to a change of 0.16260707 over the same period for the S&P500. Over the past 52 weeks, CLSD has reached a high of $1.65, while it has fallen to a 52-week low of $0.29. The 50-Day Moving Average of the stock is -55.52%, while the 200-Day Moving Average is calculated to be -62.70%.
Shares Statistics:
The stock has traded on average 439.42K shares per day over the past 3-months and 1617720 shares per day over the last 10 days, according to various share statistics. A total of 77.27M shares are outstanding, with a floating share count of 61.36M. Insiders hold about 21.04% of the company’s shares, while institutions hold 13.28% stake in the company. Shares short for CLSD as of 1751241600 were 396961 with a Short Ratio of 0.90, compared to 1748563200 on 124168. Therefore, it implies a Short% of Shares Outstanding of 396961 and a Short% of Float of 0.52.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
A comprehensive evaluation of Clearside Biomedical Inc (CLSD) is underway, with the input of 7.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.07 and low estimates of -$0.13.
Analysts are recommending an EPS of between -$0.18 and -$0.63 for the fiscal current year, implying an average EPS of -$0.41. EPS for the following year is -$0.61, with 7.0 analysts recommending between -$0.2 and -$1.3.
Revenue Estimates
A total of 7 analysts have provided revenue estimates for CLSD’s current fiscal year. The highest revenue estimate was $10.3M, while the lowest revenue estimate was $2.3M, resulting in an average revenue estimate of $3.97M. In the same quarter a year ago, actual revenue was $1.66M
